2022
Characteristics and treatment of hospitalized pregnant women with COVID-19
Sekkarie A, Woodruff R, Whitaker M, Kramer M, Zapata L, Ellington S, Meaney-Delman D, Pham H, Patel K, Taylor C, Chai S, Kawasaki B, Meek J, Openo K, Weigel A, Leegwater L, Como-Sabetti K, Ropp S, Muse A, Bennett N, Billing L, Sutton M, Talbot H, Hill M, Havers F, Team C. Characteristics and treatment of hospitalized pregnant women with COVID-19. American Journal Of Obstetrics & Gynecology MFM 2022, 4: 100715. PMID: 35970493, PMCID: PMC9371979, DOI: 10.1016/j.ajogmf.2022.100715.Peer-Reviewed Original ResearchMeSH KeywordsAntiviral AgentsCOVID-19COVID-19 VaccinesFemaleHumansInfant, NewbornPregnancyPregnant WomenSARS-CoV-2SteroidsConceptsSymptomatic COVID-19Pregnant womenSystemic steroidsCOVID-19 vaccinationVaccination statusPregnant patientsNonpregnant womenCOVID-19Laboratory-confirmed SARS-CoV-2 infectionPregnancy statusPropensity score-matched cohortCOVID-19-Associated Hospitalization Surveillance NetworkSARS-CoV-2 infectionMedical chart abstractionTreatment-eligible patientsAdverse pregnancy outcomesSymptomatic pregnant womenCOVID-19 vaccination statusHospitalized pregnant womenNon-Hispanic blacksImplementation of treatmentHospitalized womenChart abstractionClinical characteristicsPregnancy outcomes
2016
Increased Antiviral Treatment Among Hospitalized Children and Adults With Laboratory-Confirmed Influenza, 2010–2015
Appiah GD, Chaves SS, Kirley PD, Miller L, Meek J, Anderson E, Oni O, Ryan P, Eckel S, Lynfield R, Bargsten M, Zansky SM, Bennett N, Lung K, McDonald-Hamm C, Thomas A, Brady D, Lindegren ML, Schaffner W, Hill M, Garg S, Fry AM, Campbell AP. Increased Antiviral Treatment Among Hospitalized Children and Adults With Laboratory-Confirmed Influenza, 2010–2015. Clinical Infectious Diseases 2016, 64: 364-367. PMID: 28013261, PMCID: PMC5480237, DOI: 10.1093/cid/ciw745.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAntiviral AgentsChildChild, PreschoolCohort StudiesFemaleHumansInfantInfant, NewbornInfluenza A Virus, H1N1 SubtypeInfluenza, HumanLength of StayLongitudinal StudiesMaleMiddle AgedOseltamivirPandemicsProspective StudiesRetrospective StudiesSeasonsUnited StatesYoung AdultEffectiveness of Residential Acaricides to Prevent Lyme and Other Tick-borne Diseases in Humans
Hinckley A, Meek J, Ray J, Niesobecki S, Connally N, Feldman K, Jones E, Backenson P, White J, Lukacik G, Kay A, Miranda W, Mead P. Effectiveness of Residential Acaricides to Prevent Lyme and Other Tick-borne Diseases in Humans. The Journal Of Infectious Diseases 2016, 214: 182-188. PMID: 26740276, PMCID: PMC10874626, DOI: 10.1093/infdis/jiv775.Peer-Reviewed Original ResearchConceptsTick-borne diseasesHuman-tick encountersMajor public health concernPlacebo-controlled trialMedical record reviewHuman tick-borne diseasesReports of illnessPublic health concernPublic health authoritiesTick-borne diseaseRecord reviewTick biteTick exposureTreatment groupsHealth authoritiesDiseaseHealth concernQuesting ticksHuman outcomesTicksUse of acaricidesIllnessIncidenceTrialsWeeks
2014
The Burden of Influenza Hospitalizations in Infants From 2003 to 2012, United States
Chaves S, Perez A, Farley M, Miller L, Schaffner W, Lindegren M, Sharangpani R, Meek J, Yousey-Hindes K, Thomas A, Boulton R, Baumbach J, Hancock E, Bandyopadhyay A, Lynfield R, Morin C, Zansky S, Reingold A, Bennett N, Ryan P, Fowler B, Fry A, Finelli L. The Burden of Influenza Hospitalizations in Infants From 2003 to 2012, United States. The Pediatric Infectious Disease Journal 2014, 33: 912-919. PMID: 24577042, DOI: 10.1097/inf.0000000000000321.Peer-Reviewed Original ResearchConceptsImpact of influenzaHigh-risk conditionsHospitalization ratesRisk factorsOlder infantsIntensive care unit admissionInfluenza-associated hospitalization ratesCare unit admissionRisk conditionsInfluenza hospitalizationsUnit admissionICU admissionInfluenza vaccinationRespiratory failureClinical characteristicsInfant hospitalizationHealthy infantsMost hospitalizationsPregnant womenLung diseaseCardiovascular diseaseUS infantsHospitalizationYoung infantsInfants
2012
Reduced Influenza Antiviral Treatment Among Children and Adults Hospitalized With Laboratory-Confirmed Influenza Infection in the Year After the 2009 Pandemic
Garg S, Chaves SS, Pérez A, D'Mello T, Gershman K, Meek J, Yousey-Hindes K, Arnold KE, Farley MM, Tengelsen L, Ryan P, Sharangpani R, Lynfield R, Morin C, Baumbach J, Hancock EB, Zansky S, Bennett NM, Fowler B, Bradley K, Thomas A, Cooper T, Schaffner W, Boulton R, Finelli L, Fry AM. Reduced Influenza Antiviral Treatment Among Children and Adults Hospitalized With Laboratory-Confirmed Influenza Infection in the Year After the 2009 Pandemic. Clinical Infectious Diseases 2012, 55: e18-e21. PMID: 22543024, DOI: 10.1093/cid/cis442.Peer-Reviewed Original Research
2010
Influenza-Associated Pneumonia in Children Hospitalized With Laboratory-Confirmed Influenza, 2003–2008
Dawood FS, Fiore A, Kamimoto L, Nowell M, Reingold A, Gershman K, Meek J, Hadler J, Arnold KE, Ryan P, Lynfield R, Morin C, Baumbach J, Zansky S, Bennett NM, Thomas A, Schaffner W, Kirschke D, Finelli L. Influenza-Associated Pneumonia in Children Hospitalized With Laboratory-Confirmed Influenza, 2003–2008. The Pediatric Infectious Disease Journal 2010, 29: 585-590. PMID: 20589966, PMCID: PMC5856105, DOI: 10.1097/inf.0b013e3181d411c5.Peer-Reviewed Original ResearchConceptsInfluenza-associated pneumoniaChest radiographsHospitalized childrenIntensive care unit admissionCare unit admissionLaboratory-confirmed influenzaSevere clinical courseInfluenza complicationsUnit admissionRespiratory failureCommon complicationClinical courseInfluenza seasonTreatment strategiesPneumoniaMultivariate analysisNew pneumoniaGreater riskInfluenzaRadiographsAge 6Age 2HospitalizationAsthmaComplications
2001
Early-Onset Neonatal Sepsis in the Era of Group B Streptococcal Prevention
Baltimore R, Huie S, Meek J, Schuchat A, O'Brien K. Early-Onset Neonatal Sepsis in the Era of Group B Streptococcal Prevention. Pediatrics 2001, 108: 1094-1098. PMID: 11694686, DOI: 10.1542/peds.108.5.1094.Peer-Reviewed Original ResearchMeSH KeywordsAntibiotic ProphylaxisBacterial InfectionsConnecticutCross InfectionDrug ResistanceFemaleFetal Membranes, Premature RuptureGram-Negative Bacterial InfectionsGram-Positive Bacterial InfectionsHumansInfant, NewbornMaleMedical RecordsMeningitis, BacterialPregnancySex DistributionStreptococcal InfectionsStreptococcus agalactiaeConceptsColi infectionNeonatal group B streptococcal diseaseClinical microbiology laboratory recordsGroup B streptococcal diseaseAmpicillin-resistant infectionsContinuation of surveillanceOnset neonatal infectionEarly-onset sepsisIntrapartum antibiotic prophylaxisOnset neonatal sepsisE coli infectionMicrobiology laboratory recordsEarly-onset infectionNinth Revision codesEscherichia coli infectionInvasive neonatal diseaseAntibiotic prophylaxisGBS sepsisChart reviewNeonatal sepsisNeonatal infectionAnnual incidenceStreptococcal diseaseMicrobiology recordsRevision codes